ScreenerHero
ADUSAddus HomeCare Corporation
NAS · US · Healthcare · Medical Care Facilities · addus.com
121.01USD+0.82%Mkt Cap: 2.24B $P/E: 21.02

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA Inhaber-Aktien o.N.
$28.29BUSDP/E 16.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG & Co. KGaA
$11.94BUSDP/E 12.3
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
Emeis SA
$2.46BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5

Key Statistics

Company
Market Cap2.24B $
Enterprise Value2.21B $
Revenue (TTM)1.48B $
Gross Profit461.87M $
Net Income (TTM)95.91M $
Revenue/Share81.26 USD
Last Price121.01 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6.0K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISINUS0067391062
Valuation
P/E (Trailing)21.02
P/E (Forward)16.03
PEG1.10
EV/EBITDA13.33
EV/Revenue1.50
P/S1.52
P/B1.92
EPS (TTM)5.73
EPS (Forward)7.52
52W Range
87.9591% of range124.44
52W High124.44 USD
52W Low87.95 USD
Profitability
Gross Margin32.47%
Oper. Margin10.32%
EBITDA Margin11.25%
Profit Margin6.74%
ROE8.84%
ROA6.67%
Growth
Revenue Growth8.00%
Earnings Growth24.20%
Cash Flow & Leverage
Operating CF111.51M $
CapEx (TTM)7.72M $
FCF Margin8.11%
FCF Yield5.35%
Net Debt9.25M $
Net Debt/EBITDA0.06
Balance Sheet
Debt/Equity0.16
Current Ratio1.69
Quick Ratio1.46
Book Value/Sh62.77 USD
Cash/Share5.443 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)134.69 USD
Upside (mean)+11.3%
Target Range96.00 USD – 155.00 USD
$96.00+11.3% to mean$155.00
# Analysts13
Ownership
Shares Out.18.66M
Float17.75M
Insiders2.81%
Institutions107.99%
Short Interest
Short Ratio4.9d
Short % Float7.78%
Short % Out.6.46%
Shares Short1.21M
Short (prev mo.)1.06M
Technical
SMA 50108.66 (+11.4%)
SMA 200105.34 (+14.9%)
Beta0.86
S&P 52W Chg18.16%
Avg Vol (30d)218.46K
Avg Vol (10d)186.30K
Technical Indicators
RSI (14)62.9
MACD2.8545
MACD Signal3.4852
MACD Hist.-0.6307
BB Upper121.58 USD
BB Middle116.61 USD
BB Lower111.65 USD
BB Width8.52%
ATR (14)3.561 USD
Vol Ratio (20d)0.93x